Mason R. Jenkins

Mason R. Jenkins

Auto-generated profile, based on publicly available information

Mason R. Jenkins

A Northeastern University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Business Research
Verified
Journal Article
Closed access
PFPaul W. Fombelle
Paul W. Fombelle
CVClay M. Voorhees
Clay M. Voorhees
MJMason R. Jenkins
Mason R. Jenkins
KSKarim Sidaoui
Karim Sidaoui
SBSabine Benoit
Sabine Benoit
IAIbrahim Abosag
Ibrahim Abosag

18 September 2013 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
JLJosé A Larrauri
José A Larrauri
LKLisalynn D Kelley
Lisalynn D Kelley
MJMason R Jenkins
Mason R Jenkins
EWEric C Westman
Eric C Westman
NSNestor A Schmajuk
Nestor A Schmajuk
ELEdward D Levin
Edward D Levin
Histamine H1 receptor systems have been shown in animal studies to have important roles in the reversal of sensorimotor gating deficits, as measured by prepulse inhibition (PPI). H1-antagonist treatment attenuates the PPI impairments caused by either blockade of NMDA glutamate receptors or facilitation of dopamine transmission. The current experiment brought the investigation of H1 effects on sensorimotor gating to human studies. The effects of the histamine H1 antagonist meclizine on the startle response and PPI were investigated in healthy male subjects with high baseline startle responses and low PPI levels. Meclizine was administered to participants (n=24) using a within-subjects design with each participant receiving 0, 12.5, and 25 mg of meclizine in a counterbalanced order. Startle response, PPI, heart rate response, galvanic skin response, and changes in self-report ratings of alertness levels and affective states (arousal and valence) were assessed. When compared with the control (placebo) condition, the two doses of meclizine analyzed (12.5 and 25 mg) produced significant increases in PPI without affecting the magnitude of the startle response or other physiological variables. Meclizine also caused a significant increase in overall self-reported arousal levels, which was not correlated with the observed increase in PPI. These results are in agreement with previous reports in the animal literature and suggest that H1 antagonists may have beneficial effects in the treatment of subjects with compromised sensorimotor gating and enhanced motor responses to sensory stimuli.

3 December 2025 in Journal of Consumer Research
Verified
Journal Article
Closed access
MJMason R Jenkins
Mason R Jenkins
PFPaul W Fombelle
Paul W Fombelle
MSMary Steffel
Mary Steffel
Technological advancements enable firms to anticipate service failures and apologize to consumers more effectively than ever. However, are apologies always the best policy? Five experiments, including a large-scale field experiment, demonstrate that apologies backfire when consumers are not aware of the failure. Apologies decrease consumer satisfaction, trust, recommendation intentions, and repatronage behavior. This is because apologies increase awareness that a failure occurred. Accordingly, apologies backfire for both mild and severe failures so long as there is room to increase awareness of the failure. Moreover, apologies backfire more than notifications about a service failure because although both increase awareness of the aspect of the service experience that was a failure, apologies uniquely increase awareness that this constituted a failure. Beyond increasing awareness, apologies backfire by decreasing perceived service quality and competence. However, apologies also increase perceived warmth and honesty. Consequently, apologizing can be beneficial when consumers are already aware of a failure because apologies are less likely to backfire and more likely to enhance positive perceptions of the firm. These findings challenge the conventional wisdom that apologies are always the best policy when something goes wrong and provide insight into when and when not to apologize.

11 January 2018 in The Journal of Psychology
Verified
Journal Article
Closed access
MJMason R. Jenkins
Mason R. Jenkins
NKNancy S. Kim
Nancy S. Kim
When causal life-event explanations for disorder symptoms are available, clinicians tend to explain away those symptoms (Ahn, Novick, & Kim, 2003 Ahn, W. , Novick, L. R. , & Kim, N. S. (2003). Understanding behavior makes it normal. Psychonomic Bulletin Review, 10(3), 746–752. doi:10.3758/BF03196541 [Crossref], [PubMed], [Web of Science ®] [Google Scholar] ; Meehl, 1973 Meehl, P. E. (1973). Why I do not attend case conferences. In P. Meehl (Ed.), Psychodiagnosis: Selected papers (pp. 225–302). Minneapolis, MN : University of Minnesota Press. [Google Scholar] ), eschewing formal diagnostic guidelines such as the DSM-5 (American Psychiatric Association, 2013 American Psychiatric Association [APA]. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA : American Psychiatric Publishing. [Crossref] [Google Scholar] ). We asked whether this effect is attenuated in the context of a structured diagnostic clinical interview procedure, which deliberately directs evaluators' attention to symptoms alone, or whether it is robust enough to continue to emerge. Across two experiments, lay evaluators given causal life-event explanations for disordered behaviors gave them lower judgments of abnormality and need for treatment compared to evaluators not given such explanations, regardless of whether they used a structured clinical interview. Thus, causal life-event explanations may have significant impact on clinical evaluations regardless of the mode of assessment. Implications for the clinical utility of structured interviews and the role of life-event context in diagnosis and classification are discussed.